US StockDetailed Quotes

Provided by Tiger Trade Technology Pte. Ltd.

Acrivon Therapeutics, Inc.

2.07

-0.0050-0.24%

Volume:47.32K

Turnover:99.52K

Market Cap:88.38M

PE:-1.10

High:2.20

Open:2.07

Low:2.05

Close:2.07

52wk High:3.56

52wk Low:1.27

Shares:42.80M

Float Shares:25.69M

Volume Ratio:0.69

T/O Rate:0.18%

Dividend:- -

Dividend Rate:- -

EPS(TTM):-1.8800

EPS(LYR):-2.0151

ROE:-64.63%

ROA:-38.02%

PB:1.02

PE(LYR):-1.02

Loading ...

Overview Company News Filings

Acrivon net loss narrows to $19 million in Q1 FY26

Acrivon Reports First Quarter 2026 Financial Results and Highlights Progress Towards Key 2026 Clinical Catalysts

THOMSON REUTERS

Acrivon Therapeutics, Inc Q1 Income From Operations USD -19.902 Million

THOMSON REUTERS

Acrivon Therapeutics announces annual shareholder meeting

Acrivon flags preclinical synergy data for ACR-368, ACR-2316 with PD-L1 blockade

BRIEF-Acrivon Therapeutics Announces Inducement Grant Under Nasdaq Listing Rule 5635(C)(4)

Acrivon Therapeutics grants new hire options to buy 111,150 shares under inducement plan

We're Keeping An Eye On Acrivon Therapeutics' (NASDAQ:ACRV) Cash Burn Rate

Simply Wall St.

Jefferies Keeps Their Buy Rating on Acrivon Therapeutics, Inc. (ACRV)

Acrivon Therapeutics Q4 net loss narrows as expenses fall

BRIEF-Acrivon Therapeutics, Inc Q4 Income From Operations USD -20.116 Million

Acrivon Therapeutics, Inc Q4 Net Income USD -18.985 Million

THOMSON REUTERS

Press Release: Acrivon Therapeutics Reports Fourth Quarter and Full Year 2025 Financial Results and Recent Business Highlights

Acrivon FY 2025 net loss narrows 5.4% to USD 77.9 million as interest income falls 29.6% to USD 6.48 million

Acrivon Therapeutics to present three posters at the AACR Annual Meeting

{"basename":"","ssrTDKData":{"titleTemplate":"%s - Tiger Brokers","title":"Tiger Brokers | Global Stocks, Options & Futures Trading App","description":"Tiger Brokers, one-stop investment in US stocks, SGX stocks, HK stocks, A-shares & other global assets. One of the best stock trading platforms in Singapore.","keywords":"tiger brokers,tiger trade,tiger brokers singapore,broker online,stock trading in singapore,share trading singapore,brokerage firm singapore,trading app,stock broker singapore,stock trading platforms,trading account","social":{"ogDescription":"Tiger Brokers, one-stop investment in US stocks, SGX stocks, HK stocks, A-shares & other global assets. One of the best stock trading platforms in Singapore.","ogImage":"https://c1.itigergrowtha.com/portal5/static/media/og-logo.0a0bd8dc.png","ogUrl":"https://au1.tigerplaytime.com/stock/ACRV/news?page=2"},"companyName":"Tiger Brokers"},"pageData":{"isMobile":false,"isTiger":false,"isTTM":true,"region":"SGP","license":"TBSG","edition":"fundamental","symbol":"ACRV","isAnalysisPage":false},"__swrFallback__":{"@#url:\"https://hq.skytigris.cn/stock_info/detail/global\",params:#delay:false,,method:\"POST\",data:#items:@#symbol:\"ACRV\",,,,,undefined,":{"symbol":"ACRV","market":"US","secType":"STK","nameCN":"Acrivon Therapeutics, Inc.","latestPrice":2.065,"timestamp":1788363145352,"preClose":2.07,"halted":0,"volume":47319,"delay":0,"changeRate":-0.0024154589371980163,"floatShares":25689899,"shares":42801400,"eps":-1.88,"marketStatus":"Trading","change":-0.005,"latestTime":"09-02 11:33:12 EDT","open":2.07,"high":2.2,"low":2.05,"amount":99515.48636729999,"amplitude":0.072464,"askPrice":2.07,"askSize":386,"bidPrice":2.06,"bidSize":208,"shortable":3,"etf":0,"ttmEps":-1.88,"tradingStatus":2,"nextMarketStatus":{"tag":"Post-Mkt","tradingStatus":3,"beginTime":1788379200000},"marketStatusCode":2,"adr":0,"listingDate":1668488400000,"exchange":"NASDAQ","adjPreClose":2.07,"preHourTrading":{"tag":"盘前","latestPrice":2.06,"preClose":2.07,"latestTime":"08:48 EDT","volume":715,"amount":1473.8999275,"timestamp":1788353339527,"change":-0.01,"changeRate":-0.004831,"amplitude":0.019324},"postHourTrading":{"tag":"盘后","latestPrice":2.07,"preClose":2.07,"latestTime":"19:30 EDT","volume":10,"amount":20.7,"timestamp":1788305405952,"change":0,"changeRate":0,"amplitude":0},"volumeRatio":0.686961},"@#url:\"https://hq.skytigris.cn/stock_info/fundamental/all\",params:#delay:false,,method:\"POST\",data:#items:@#symbol:\"ACRV\",,,,,undefined,":{"symbol":"ACRV","floatShares":25689899,"roa":"-38.02%","roe":"-64.63%","lyrEps":-2.015099,"volumeRatio":0.686961,"shares":42801400,"dividePrice":0,"high":2.2,"amplitude":0.072464,"preClose":2.07,"low":2.05,"week52Low":1.27,"pbRate":"1.02","week52High":3.56,"institutionHeld":0,"latestPrice":2.065,"committee":-0.299663,"eps":-1.88,"divideRate":0,"volume":47319,"delay":0,"ttmEps":-1.88,"open":2.07,"prevYearClose":2.41,"prevWeekClose":2.06,"prevMonthClose":2.09,"prevQuarterClose":1.78,"fiveDayClose":2.08,"twentyDayClose":1.64,"sixtyDayClose":1.41},"@#url:\"https://hq.skytigris.cn/fundamental/corporate_actions/details/ACRV\",params:#limit:5,,,undefined,":[{"market":"US","date":"2026-08-12","symbol":"ACRV","fiscalQuarterEnding":"2026/06","expectedEps":-0.49,"name":null,"time":"Post-Mkt","type":"earning","dateTimestamp":1786507200000,"reportTimeType":"post","actualEps":-0.43},{"market":"US","date":"2026-05-13","symbol":"ACRV","fiscalQuarterEnding":"2026/03","expectedEps":-0.49,"name":null,"time":"Post-Mkt","type":"earning","dateTimestamp":1778644800000,"reportTimeType":"post","actualEps":-0.49},{"market":"US","date":"2026-03-19","symbol":"ACRV","fiscalQuarterEnding":"2025/12","expectedEps":-0.49,"name":null,"time":"Pre-MKt","type":"earning","dateTimestamp":1773892800000,"reportTimeType":"pre","actualEps":-0.49},{"market":"US","date":"2025-11-13","symbol":"ACRV","fiscalQuarterEnding":"2025/09","expectedEps":-0.57,"name":null,"time":"Post-Mkt","type":"earning","dateTimestamp":1763010000000,"reportTimeType":"post","actualEps":-0.47},{"market":"US","date":"2025-08-13","symbol":"ACRV","fiscalQuarterEnding":"2025/06","expectedEps":-0.57,"name":null,"time":"Post-Mkt","type":"earning","dateTimestamp":1755057600000,"reportTimeType":"post","actualEps":-0.55}],"@#url:\"https://hq.skytigris.cn/fundamental/dividend/history\",params:#symbol:\"ACRV\",market:\"US\",,,undefined,":[],"@#url:\"https://hq.skytigris.cn/fundamental/estimate/recommendation\",params:#symbol:\"ACRV\",market:\"US\",delay:false,,,undefined,":{"strongBuy":0.2857,"buy":0.7143,"hold":0,"sell":0,"strongSell":0,"meanLabel":"BUY","meanPercent":0.7143,"analysts":7,"updateTime":1747454400000},"@#url:\"https://hq.skytigris.cn/value_analysis/stock/ACRV\",params:#withQuantilePoint:true,period:\"5year\",factor:\"peRate\",delay:false,algorithm:1,,,undefined,":{"brief":{"id":"ACRV","date":"2026-08-31","current":-1.101064,"percent":0.625,"low":-18.228389,"twenty":-5.953188,"median":-2.252014,"eighty":-0.728484,"high":-0.393112,"avg":-3.65689,"sd":3.912144,"marketCap":88277925},"quantilePoints":[{"date":"2022-11-11","current":-11.86111,"twenty":-16.13111,"median":-16.13111,"eighty":-13.56911,"marketCap":235122787},{"date":"2022-11-18","current":-16.605358,"twenty":-17.148347,"median":-16.336664,"eighty":-13.56911,"marketCap":329168006},{"date":"2022-11-25","current":-13.1538,"twenty":-16.59273,"median":-14.65824,"eighty":-13.1538,"marketCap":260747787},{"date":"2022-12-02","current":-13.311646,"twenty":-16.459997,"median":-13.18537,"eighty":-13.1538,"marketCap":263876760},{"date":"2022-12-09","current":-13.1538,"twenty":-16.13111,"median":-13.18537,"eighty":-13.1538,"marketCap":260747787},{"date":"2022-12-16","current":-9.42062,"twenty":-15.609309,"median":-13.164324,"eighty":-13.1538,"marketCap":250409495},{"date":"2022-12-23","current":-9.15348,"twenty":-13.492642,"median":-13.1538,"eighty":-9.908718,"marketCap":243308642},{"date":"2022-12-30","current":-9.051338,"twenty":-13.374784,"median":-13.1538,"eighty":-9.15348,"marketCap":240593610},{"date":"2023-01-06","current":-9.114194,"twenty":-13.324274,"median":-13.1538,"eighty":-9.10948,"marketCap":242264399},{"date":"2023-01-13","current":-9.758474,"twenty":-13.286391,"median":-13.1538,"eighty":-9.096909,"marketCap":259389986},{"date":"2023-01-20","current":-11.102032,"twenty":-13.261136,"median":-11.86111,"eighty":-9.107908,"marketCap":295103100},{"date":"2023-01-27","current":-11.416314,"twenty":-13.210625,"median":-11.432028,"eighty":-9.118908,"marketCap":303457044},{"date":"2023-02-03","current":-14.967707,"twenty":-13.261136,"median":-11.549884,"eighty":-9.140908,"marketCap":397856621},{"date":"2023-02-10","current":-17.254113,"twenty":-13.707494,"median":-12.294777,"eighty":-9.280764,"marketCap":458631569},{"date":"2023-02-17","current":-16.963401,"twenty":-16.209458,"median":-13.1538,"eighty":-9.39862,"marketCap":450904170},{"date":"2023-02-24","current":-12.044879,"twenty":-16.13111,"median":-12.885585,"eighty":-9.423763,"marketCap":320164934},{"date":"2023-03-03","current":-16.499835,"twenty":-16.177918,"median":-13.1538,"eighty":-9.434763,"marketCap":438582102},{"date":"2023-03-10","current":-15.745556,"twenty":-16.430693,"median":-13.1538,"eighty":-9.447334,"marketCap":418532634},{"date":"2023-03-17","current":-15.714128,"twenty":-16.525265,"median":-13.1538,"eighty":-9.527476,"marketCap":417697240},{"date":"2023-03-24","current":-10.229897,"twenty":-16.430693,"median":-13.1538,"eighty":-9.461476,"marketCap":271920903},{"date":"2023-03-31","current":-8.928026,"twenty":-16.282979,"median":-13.1538,"eighty":-9.434763,"marketCap":278259784},{"date":"2023-04-06","current":-7.274688,"twenty":-16.215409,"median":-13.019693,"eighty":-9.37662,"marketCap":226730194},{"date":"2023-04-14","current":-6.723819,"twenty":-16.19352,"median":-12.044879,"eighty":-9.115765,"marketCap":209561261},{"date":"2023-04-21","current":-8.060143,"twenty":-16.13111,"median":-11.86111,"eighty":-9.056052,"marketCap":251210465},{"date":"2023-04-28","current":-8.650938,"twenty":-16.126284,"median":-11.549884,"eighty":-9.035624,"marketCap":269623798},{"date":"2023-05-05","current":-7.956584,"twenty":-16.088124,"median":-11.377028,"eighty":-8.91982,"marketCap":247982856},{"date":"2023-05-12","current":-8.118522,"twenty":-16.003268,"median":-11.21203,"eighty":-8.835959,"marketCap":297974095},{"date":"2023-05-19","current":-7.88554,"twenty":-15.962411,"median":-10.807392,"eighty":-8.673871,"marketCap":289422962},{"date":"2023-05-26","current":-7.467367,"twenty":-15.908983,"median":-10.229897,"eighty":-8.438641,"marketCap":274074775},{"date":"2023-06-02","current":-7.419576,"twenty":-15.745556,"median":-9.829187,"eighty":-8.257075,"marketCap":272320696},{"date":"2023-06-09","current":-7.353863,"twenty":-15.714128,"median":-9.671273,"eighty":-8.064756,"marketCap":269908838},{"date":"2023-06-16","current":-7.138803,"twenty":-14.967707,"median":-9.475619,"eighty":-7.88554,"marketCap":262015484},{"date":"2023-06-23","current":-7.694375,"twenty":-14.936279,"median":-9.444191,"eighty":-7.691985,"marketCap":282406648},{"date":"2023-06-30","current":-7.957226,"twenty":-14.607853,"median":-9.4246,"eighty":-7.737387,"marketCap":292054080},{"date":"2023-07-07","current":-6.962573,"twenty":-14.230714,"median":-9.36562,"eighty":-7.687206,"marketCap":255547320},{"date":"2023-07-14","current":-7.312046,"twenty":-13.800187,"median":-9.122051,"eighty":-7.479315,"marketCap":268374019},{"date":"2023-07-21","current":-7.795931,"twenty":-13.463178,"median":-9.09848,"eighty":-7.467367,"marketCap":286134065},{"date":"2023-07-28","current":-7.335941,"twenty":-13.349529,"median":-9.063123,"eighty":-7.467367,"marketCap":269251058},{"date":"2023-08-04","current":-7.049195,"twenty":-13.305332,"median":-9.04741,"eighty":-7.451835,"marketCap":258726587},{"date":"2023-08-11","current":-6.929717,"twenty":-13.273763,"median":-9.035624,"eighty":-7.414797,"marketCap":254341391},{"date":"2023-08-18","current":-5.439761,"twenty":-13.23588,"median":-8.933664,"eighty":-7.374175,"marketCap":243684992},{"date":"2023-08-25","current":-5.824092,"twenty":-13.18537,"median":-8.917768,"eighty":-7.335941,"marketCap":260901867},{"date":"2023-09-01","current":-5.774819,"twenty":-13.181161,"median":-8.846512,"eighty":-7.295319,"marketCap":258694575},{"date":"2023-09-08","current":-5.764965,"twenty":-13.164324,"median":-8.810263,"eighty":-7.252307,"marketCap":258253117},{"date":"2023-09-15","current":-5.415125,"twenty":-13.164324,"median":-8.657972,"eighty":-7.138803,"marketCap":242581346},{"date":"2023-09-22","current":-4.666172,"twenty":-13.15801,"median":-8.650938,"eighty":-7.070701,"marketCap":209030514},{"date":"2023-09-28","current":-4.848483,"twenty":-13.1538,"median":-8.470778,"eighty":-7.024104,"marketCap":217197493},{"date":"2023-10-06","current":-3.606798,"twenty":-13.1538,"median":-8.337045,"eighty":-6.962573,"marketCap":161573745},{"date":"2023-10-13","current":-3.074648,"twenty":-13.1538,"median":-8.233741,"eighty":-6.723819,"marketCap":137734995},{"date":"2023-10-20","current":-2.670607,"twenty":-13.1538,"median":-8.118522,"eighty":-6.217422,"marketCap":119635204},{"date":"2023-10-27","current":-2.498151,"twenty":-13.1538,"median":-8.106574,"eighty":-6.135872,"marketCap":111909684},{"date":"2023-11-03","current":-2.650898,"twenty":-13.1538,"median":-8.060143,"eighty":-5.913769,"marketCap":118752288},{"date":"2023-11-10","current":-2.023663,"twenty":-13.1538,"median":-7.990082,"eighty":-5.83986,"marketCap":101314684},{"date":"2023-11-17","current":-1.968296,"twenty":-13.1538,"median":-7.956584,"eighty":-5.774819,"marketCap":98542723},{"date":"2023-11-24","current":-1.70231,"twenty":-13.1538,"median":-7.867618,"eighty":-5.710764,"marketCap":85226138},{"date":"2023-12-01","current":-1.795405,"twenty":-12.885585,"median":-7.837749,"eighty":-5.538308,"marketCap":89886943},{"date":"2023-12-08","current":-2.38944,"twenty":-12.728444,"median":-7.795931,"eighty":-5.434834,"marketCap":119627314},{"date":"2023-12-15","current":-2.220982,"twenty":-12.181592,"median":-7.694375,"eighty":-5.139195,"marketCap":111193478},{"date":"2023-12-22","current":-2.158919,"twenty":-11.988308,"median":-7.676453,"eighty":-4.765704,"marketCap":108086275},{"date":"2023-12-29","current":-2.207683,"twenty":-11.903452,"median":-7.658532,"eighty":-4.607044,"marketCap":110527648},{"date":"2024-01-05","current":-2.061391,"twenty":-11.878047,"median":-7.57191,"eighty":-4.424734,"marketCap":103203527},{"date":"2024-01-12","current":-2.136753,"twenty":-11.86111,"median":-7.467367,"eighty":-3.380635,"marketCap":106976559},{"date":"2024-01-19","current":-1.928398,"twenty":-11.771191,"median":-7.467367,"eighty":-3.021433,"marketCap":96545235},{"date":"2024-01-26","current":-1.795405,"twenty":-11.601741,"median":-7.461393,"eighty":-2.812514,"marketCap":89886943},{"date":"2024-02-02","current":-1.711176,"twenty":-11.509027,"median":-7.449445,"eighty":-2.678491,"marketCap":85670025},{"date":"2024-02-09","current":-1.569317,"twenty":-11.435171,"median":-7.416589,"eighty":-2.525448,"marketCap":78567846},{"date":"2024-02-16","current":-1.773239,"twenty":-11.384886,"median":-7.389706,"eighty":-2.417812,"marketCap":88777228},{"date":"2024-02-23","current":-1.693444,"twenty":-11.315743,"median":-7.371785,"eighty":-2.305211,"marketCap":84782252},{"date":"2024-03-01","current":-2.154486,"twenty":-11.224602,"median":-7.341915,"eighty":-2.222755,"marketCap":107864332},{"date":"2024-03-08","current":-2.274179,"twenty":-11.19003,"median":-7.329968,"eighty":-2.220982,"marketCap":113856794},{"date":"2024-03-15","current":-2.247581,"twenty":-11.059604,"median":-7.297111,"eighty":-2.213003,"marketCap":112525136},{"date":"2024-03-22","current":-2.806151,"twenty":-10.856891,"median":-7.272415,"eighty":-2.217436,"marketCap":140489963},{"date":"2024-03-28","current":-2.376071,"twenty":-10.724892,"median":-7.222437,"eighty":-2.220982,"marketCap":143486194},{"date":"2024-04-05","current":-2.507803,"twenty":-10.284897,"median":-7.147764,"eighty":-2.220982,"marketCap":151441202},{"date":"2024-04-12","current":-3.482435,"twenty":-10.229897,"median":-7.085038,"eighty":-2.220982,"marketCap":210297274},{"date":"2024-04-19","current":-5.388706,"twenty":-10.049185,"median":-7.03426,"eighty":-2.229848,"marketCap":325413151},{"date":"2024-04-26","current":-4.330392,"twenty":-9.829187,"median":-6.98405,"eighty":-2.238715,"marketCap":261503737},{"date":"2024-05-03","current":-4.325468,"twenty":-9.758474,"median":-6.941664,"eighty":-2.247581,"marketCap":261206357},{"date":"2024-05-10","current":-4.161857,"twenty":-9.701929,"median":-6.723819,"eighty":-2.252014,"marketCap":251326211},{"date":"2024-05-17","current":-4.122189,"twenty":-9.640618,"median":-6.484687,"eighty":-2.274179,"marketCap":264306537},{"date":"2024-05-24","current":-3.905485,"twenty":-9.530619,"median":-6.182256,"eighty":-2.300778,"marketCap":250411918},{"date":"2024-05-31","current":-3.717675,"twenty":-9.486619,"median":-5.962057,"eighty":-2.304324,"marketCap":238369915},{"date":"2024-06-07","current":-3.49134,"twenty":-9.456762,"median":-5.903338,"eighty":-2.319397,"marketCap":223857757},{"date":"2024-06-14","current":-3.49134,"twenty":-9.445762,"median":-5.863511,"eighty":-2.33713,"marketCap":223857757},{"date":"2024-06-21","current":-3.183139,"twenty":-9.434763,"median":-5.824092,"eighty":-2.361913,"marketCap":204096520},{"date":"2024-06-28","current":-2.793072,"twenty":-9.426151,"median":-5.774819,"eighty":-2.384092,"marketCap":179086205},{"date":"2024-07-05","current":-3.404659,"twenty":-9.423008,"median":-5.767428,"eighty":-2.38944,"marketCap":218299909},{"date":"2024-07-12","current":-3.587653,"twenty":-9.39862,"median":-5.666418,"eighty":-2.403626,"marketCap":230033143},{"date":"2024-07-19","current":-3.529865,"twenty":-9.280764,"median":-5.543235,"eighty":-2.426576,"marketCap":226327911},{"date":"2024-07-26","current":-4.266659,"twenty":-9.140908,"median":-5.474253,"eighty":-2.441598,"marketCap":273569617},{"date":"2024-08-02","current":-3.63581,"twenty":-9.122051,"median":-5.42498,"eighty":-2.474845,"marketCap":233120836},{"date":"2024-08-09","current":-3.703229,"twenty":-9.118908,"median":-5.388706,"eighty":-2.497195,"marketCap":237443607},{"date":"2024-08-16","current":-3.411328,"twenty":-9.107908,"median":-5.155584,"eighty":-2.500122,"marketCap":235388438},{"date":"2024-08-23","current":-4.201319,"twenty":-9.095337,"median":-5.020597,"eighty":-2.503539,"marketCap":289899445},{"date":"2024-08-30","current":-4.259671,"twenty":-9.084337,"median":-4.902952,"eighty":-2.504417,"marketCap":293925826},{"date":"2024-09-06","current":-3.62678,"twenty":-9.070195,"median":-4.859549,"eighty":-2.505321,"marketCap":250255077},{"date":"2024-09-13","current":-3.999333,"twenty":-9.051338,"median":-4.841316,"eighty":-2.507803,"marketCap":275961972},{"date":"2024-09-20","current":-3.352976,"twenty":-9.049767,"median":-4.688345,"eighty":-2.511616,"marketCap":231362057},{"date":"2024-09-27","current":-3.21383,"twenty":-9.04191,"median":-4.607044,"eighty":-2.532949,"marketCap":221760687},{"date":"2024-10-04","current":-3.146501,"twenty":-9.035624,"median":-4.498696,"eighty":-2.562206,"marketCap":217114862},{"date":"2024-10-11","current":-3.272182,"twenty":-9.016796,"median":-4.434588,"eighty":-2.595712,"marketCap":225787068},{"date":"2024-10-18","current":-3.703086,"twenty":-8.941048,"median":-4.32793,"eighty":-2.65484,"marketCap":255520344},{"date":"2024-10-25","current":-3.572917,"twenty":-8.937048,"median":-4.281106,"eighty":-2.672533,"marketCap":246538417},{"date":"2024-11-01","current":-3.59536,"twenty":-8.928026,"median":-4.264137,"eighty":-2.682254,"marketCap":248087025},{"date":"2024-11-08","current":-3.846721,"twenty":-8.925974,"median":-4.246205,"eighty":-2.692288,"marketCap":265431436},{"date":"2024-11-15","current":-2.815239,"twenty":-8.917768,"median":-4.204595,"eighty":-2.703682,"marketCap":216708620},{"date":"2024-11-22","current":-2.649398,"twenty":-8.907034,"median":-4.16553,"eighty":-2.65484,"marketCap":203942738},{"date":"2024-11-29","current":-3.066021,"twenty":-8.864099,"median":-4.160922,"eighty":-2.670607,"marketCap":236013123},{"date":"2024-12-06","current":-2.596815,"twenty":-8.828924,"median":-4.126009,"eighty":-2.650898,"marketCap":199895020},{"date":"2024-12-13","current":-2.855687,"twenty":-8.814854,"median":-4.120525,"eighty":-2.670607,"marketCap":219822249},{"date":"2024-12-20","current":-2.714117,"twenty":-8.805671,"median":-4.068333,"eighty":-2.680238,"marketCap":208924546},{"date":"2024-12-27","current":-2.394571,"twenty":-8.751109,"median":-4.0331,"eighty":-2.645353,"marketCap":184326872},{"date":"2025-01-03","current":-2.677713,"twenty":-8.689771,"median":-4.012605,"eighty":-2.604905,"marketCap":206122279},{"date":"2025-01-10","current":-2.212551,"twenty":-8.655158,"median":-3.960865,"eighty":-2.587876,"marketCap":170315539},{"date":"2025-01-17","current":-2.337942,"twenty":-8.650938,"median":-3.900584,"eighty":-2.551877,"marketCap":179967790},{"date":"2025-01-24","current":-2.204461,"twenty":-8.625618,"median":-3.852513,"eighty":-2.521343,"marketCap":169692813},{"date":"2025-01-31","current":-2.455244,"twenty":-8.502914,"median":-3.835171,"eighty":-2.504323,"marketCap":188997316},{"date":"2025-02-07","current":-2.43502,"twenty":-8.401182,"median":-3.809173,"eighty":-2.50322,"marketCap":187440501},{"date":"2025-02-14","current":-2.192327,"twenty":-8.329184,"median":-3.763471,"eighty":-2.461772,"marketCap":168758724},{"date":"2025-02-21","current":-2.240865,"twenty":-8.297738,"median":-3.75246,"eighty":-2.43502,"marketCap":172495079},{"date":"2025-02-28","current":-2.147833,"twenty":-8.257075,"median":-3.717675,"eighty":-2.390526,"marketCap":165333731},{"date":"2025-03-07","current":-2.240865,"twenty":-8.210407,"median":-3.714869,"eighty":-2.366257,"marketCap":172495079},{"date":"2025-03-14","current":-2.200416,"twenty":-8.154365,"median":-3.703229,"eighty":-2.322944,"marketCap":169381450},{"date":"2025-03-21","current":-2.168057,"twenty":-8.118522,"median":-3.698597,"eighty":-2.300778,"marketCap":166890546},{"date":"2025-03-28","current":-0.871783,"twenty":-8.106574,"median":-3.680643,"eighty":-2.269179,"marketCap":70227315},{"date":"2025-04-04","current":-0.587675,"twenty":-8.064756,"median":-3.655072,"eighty":-2.252014,"marketCap":47340734},{"date":"2025-04-11","current":-0.630486,"twenty":-8.060143,"median":-3.640625,"eighty":-2.24491,"marketCap":50789397},{"date":"2025-04-17","current":-0.704431,"twenty":-8.039938,"median":-3.63581,"eighty":-2.240865,"marketCap":56746178},{"date":"2025-04-25","current":-0.638341,"twenty":-8.020549,"median":-3.631295,"eighty":-2.235426,"marketCap":51422173},{"date":"2025-05-02","current":-0.548817,"twenty":-7.973953,"median":-3.617803,"eighty":-2.223945,"marketCap":44210527},{"date":"2025-05-09","current":-0.451509,"twenty":-7.958421,"median":-3.612522,"eighty":-2.214841,"marketCap":36371781},{"date":"2025-05-16","current":-0.430551,"twenty":-7.956712,"median":-3.606138,"eighty":-2.211394,"marketCap":36058665},{"date":"2025-05-23","current":-0.430551,"twenty":-7.899749,"median":-3.596322,"eighty":-2.204461,"marketCap":36058665},{"date":"2025-05-30","current":-0.411832,"twenty":-7.874787,"median":-3.589262,"eighty":-2.194384,"marketCap":34490897},{"date":"2025-06-06","current":-0.46799,"twenty":-7.860449,"median":-3.572307,"eighty":-2.185046,"marketCap":39194201},{"date":"2025-06-13","current":-0.475478,"twenty":-7.85567,"median":-3.556351,"eighty":-2.168057,"marketCap":39821308},{"date":"2025-06-20","current":-0.464247,"twenty":-7.841333,"median":-3.540333,"eighty":-2.161322,"marketCap":38880647},{"date":"2025-06-27","current":-0.490454,"twenty":-7.815048,"median":-3.529865,"eighty":-2.150494,"marketCap":41075522},{"date":"2025-07-03","current":-0.482966,"twenty":-7.805489,"median":-3.520234,"eighty":-2.141361,"marketCap":40448415},{"date":"2025-07-11","current":-0.50543,"twenty":-7.789957,"median":-3.49134,"eighty":-2.109268,"marketCap":42329737},{"date":"2025-07-18","current":-0.494198,"twenty":-7.751725,"median":-3.478657,"eighty":-2.07907,"marketCap":41389076},{"date":"2025-07-25","current":-0.520405,"twenty":-7.691985,"median":-3.452815,"eighty":-2.037985,"marketCap":43583951},{"date":"2025-08-01","current":-0.479222,"twenty":-7.680037,"median":-3.411328,"eighty":-2.021493,"marketCap":40134862},{"date":"2025-08-08","current":-0.475478,"twenty":-7.66809,"median":-3.410401,"eighty":-1.970956,"marketCap":39821308},{"date":"2025-08-15","current":-0.508659,"twenty":-7.656142,"median":-3.404659,"eighty":-1.930615,"marketCap":43723346},{"date":"2025-08-22","current":-0.483043,"twenty":-7.616715,"median":-3.37891,"eighty":-1.884954,"marketCap":41521451},{"date":"2025-08-29","current":-0.486703,"twenty":-7.496042,"median":-3.352976,"eighty":-1.788312,"marketCap":41836007},{"date":"2025-09-05","current":-0.475725,"twenty":-7.491263,"median":-3.313162,"eighty":-1.768806,"marketCap":40892338},{"date":"2025-09-12","current":-0.56721,"twenty":-7.467367,"median":-3.258716,"eighty":-1.720042,"marketCap":48756249},{"date":"2025-09-19","current":-0.611123,"twenty":-7.467367,"median":-3.24525,"eighty":-1.70231,"marketCap":52530927},{"date":"2025-09-26","current":-0.563551,"twenty":-7.467367,"median":-3.222807,"eighty":-1.693444,"marketCap":48441693},{"date":"2025-10-03","current":-0.680652,"twenty":-7.467367,"median":-3.207592,"eighty":-1.640246,"marketCap":58507499},{"date":"2025-10-10","current":-0.717246,"twenty":-7.461393,"median":-3.192079,"eighty":-1.613648,"marketCap":61653064},{"date":"2025-10-17","current":-0.684312,"twenty":-7.461393,"median":-3.15099,"eighty":-1.551584,"marketCap":58822056},{"date":"2025-10-24","current":-0.731884,"twenty":-7.449445,"median":-3.142012,"eighty":-0.871783,"marketCap":62911290},{"date":"2025-10-31","current":-0.709928,"twenty":-7.449445,"median":-3.137524,"eighty":-0.778377,"marketCap":61023951},{"date":"2025-11-07","current":-0.731884,"twenty":-7.431524,"median":-3.124058,"eighty":-0.764819,"marketCap":62911290},{"date":"2025-11-14","current":-0.7575,"twenty":-7.419576,"median":-3.074648,"eighty":-0.7575,"marketCap":65113185},{"date":"2025-11-21","current":-0.872339,"twenty":-7.413602,"median":-3.028172,"eighty":-0.7575,"marketCap":71314584},{"date":"2025-11-28","current":-0.910938,"twenty":-7.394485,"median":-3.011416,"eighty":-0.7575,"marketCap":74470097},{"date":"2025-12-05","current":-0.930238,"twenty":-7.389706,"median":-2.985956,"eighty":-0.763355,"marketCap":76047853},{"date":"2025-12-12","current":-1.007436,"twenty":-7.384928,"median":-2.942357,"eighty":-0.772552,"marketCap":82358878},{"date":"2025-12-19","current":-0.872339,"twenty":-7.374175,"median":-2.916361,"eighty":-0.777599,"marketCap":71314584},{"date":"2025-12-26","current":-0.922518,"twenty":-7.361032,"median":-2.855687,"eighty":-0.783416,"marketCap":75416751},{"date":"2026-01-02","current":-0.930238,"twenty":-7.351473,"median":-2.838136,"eighty":-0.788086,"marketCap":76047853},{"date":"2026-01-09","current":-0.744962,"twenty":-7.34311,"median":-2.832314,"eighty":-0.788086,"marketCap":60901393},{"date":"2026-01-16","current":-0.721803,"twenty":-7.335941,"median":-2.819283,"eighty":-0.760428,"marketCap":59008085},{"date":"2026-01-23","current":-0.783561,"twenty":-7.334746,"median":-2.806151,"eighty":-0.758852,"marketCap":64056905},{"date":"2026-01-30","current":-0.725663,"twenty":-7.326384,"median":-2.795895,"eighty":-0.7575,"marketCap":59323636},{"date":"2026-02-06","current":-0.617585,"twenty":-7.309656,"median":-2.788419,"eighty":-0.745274,"marketCap":50488201},{"date":"2026-02-13","current":-0.609865,"twenty":-7.298903,"median":-2.772248,"eighty":-0.73408,"marketCap":49857099},{"date":"2026-02-20","current":-0.609865,"twenty":-7.294124,"median":-2.745282,"eighty":-0.728225,"marketCap":49857099},{"date":"2026-02-27","current":-0.710223,"twenty":-7.274688,"median":-2.729735,"eighty":-0.721803,"marketCap":58061431},{"date":"2026-03-06","current":-0.617585,"twenty":-7.272415,"median":-2.715921,"eighty":-0.709928,"marketCap":50488201},{"date":"2026-03-13","current":-0.621445,"twenty":-7.252307,"median":-2.706027,"eighty":-0.698949,"marketCap":50803752},{"date":"2026-03-20","current":-0.688579,"twenty":-7.222437,"median":-2.690082,"eighty":-0.69163,"marketCap":53643714},{"date":"2026-03-27","current":-0.706208,"twenty":-7.174646,"median":-2.677713,"eighty":-0.69163,"marketCap":55017113},{"date":"2026-04-02","current":-0.726101,"twenty":-7.160309,"median":-2.650898,"eighty":-0.691215,"marketCap":56566891},{"date":"2026-04-10","current":-0.770861,"twenty":-7.142387,"median":-2.631196,"eighty":-0.691562,"marketCap":60053891},{"date":"2026-04-17","current":-0.83054,"twenty":-7.124465,"median":-2.604905,"eighty":-0.69163,"marketCap":64703224},{"date":"2026-04-24","current":-0.939953,"twenty":-7.092207,"median":-2.581276,"eighty":-0.69724,"marketCap":73227002},{"date":"2026-05-01","current":-0.920059,"twenty":-7.056364,"median":-2.557279,"eighty":-0.698888,"marketCap":71677225},{"date":"2026-05-08","current":-1.009579,"twenty":-7.039637,"median":-2.531504,"eighty":-0.698949,"marketCap":78651225},{"date":"2026-05-15","current":-1.063567,"twenty":-7.032468,"median":-2.507803,"eighty":-0.698949,"marketCap":82178597},{"date":"2026-05-22","current":-0.991554,"twenty":-7.021715,"median":-2.504465,"eighty":-0.701877,"marketCap":76614421},{"date":"2026-05-29","current":-0.902924,"twenty":-6.99816,"median":-2.503431,"eighty":-0.703702,"marketCap":69766205},{"date":"2026-06-05","current":-0.858608,"twenty":-6.971164,"median":-2.496557,"eighty":-0.705497,"marketCap":66342097},{"date":"2026-06-12","current":-0.797675,"twenty":-6.957196,"median":-2.457807,"eighty":-0.706301,"marketCap":61633948},{"date":"2026-06-18","current":-0.84199,"twenty":-6.944054,"median":-2.43502,"eighty":-0.707789,"marketCap":65058056},{"date":"2026-06-26","current":-0.875234,"twenty":-6.891484,"median":-2.424905,"eighty":-0.710046,"marketCap":67626731},{"date":"2026-07-02","current":-0.958326,"twenty":-6.812071,"median":-2.390526,"eighty":-0.711628,"marketCap":74046991},{"date":"2026-07-10","current":-1.135589,"twenty":-6.715379,"median":-2.382756,"eighty":-0.717797,"marketCap":87743544},{"date":"2026-07-17","current":-0.969405,"twenty":-6.663332,"median":-2.341987,"eighty":-0.72036,"marketCap":74903025},{"date":"2026-07-24","current":-0.925089,"twenty":-6.547986,"median":-2.330443,"eighty":-0.722355,"marketCap":71478887},{"date":"2026-07-31","current":-0.841998,"twenty":-6.379188,"median":-2.303374,"eighty":-0.724565,"marketCap":65058628},{"date":"2026-08-07","current":-0.936168,"twenty":-6.217422,"median":-2.300778,"eighty":-0.725663,"marketCap":72334922},{"date":"2026-08-14","current":-1.0668,"twenty":-6.182256,"median":-2.273702,"eighty":-0.726101,"marketCap":79183198},{"date":"2026-08-21","current":-1.270157,"twenty":-6.10495,"median":-2.265134,"eighty":-0.728225,"marketCap":94277396},{"date":"2026-08-28","current":-1.24129,"twenty":-5.962057,"median":-2.252507,"eighty":-0.728225,"marketCap":92134728},{"date":"2026-08-31","current":-1.189329,"twenty":-5.953188,"median":-2.252014,"eighty":-0.728484,"marketCap":88277925}],"updateTime":1788329445399},"$inf$@#url:\"https://stock-news.skytigris.cn/v2/news/list\",params:#symbols:\"ACRV\",pageSize:20,pageCount:2,lang_content:\"en\",edition:\"fundamental\",,,undefined,":[{"items":[{"id":"2635753658","title":"Acrivon net loss narrows to $19 million in Q1 FY26","url":"https://stock-news.laohu8.com/highlight/detail?id=2635753658","media":"Reuters","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2635753658?lang=en_us&edition=fundamental","pubTime":"2026-05-14 04:14","pubTimestamp":1778703295,"startTime":"0","endTime":"0","summary":"Acrivon Therapeutics posted a first-quarter net loss of USD 19 million, narrowing from a net loss of USD 19.7 million a year earlier.R&D expense held nearly flat at USD 15.2 million, while G&A expense fell to USD 4.7 million from USD 6.2 million.Cash, cash equivalents and marketable securities totaled USD 97.7 million as of March 31, 2026; subsequent equity financing added USD 7.3 million, extending expected runway into third quarter 2027.For ACR-368, Acrivon plans a prespecified simultaneous interim analysis and data update for both biopsy-independent serous endometrial cancer arms in second half 2026, with Phase 3 combination-trial readiness targeted by mid-2026.ACR-2316 Phase 1/2 data continued to show favorable tolerability mainly limited to transient neutropenia, with durable activity at weekly dosing regimens in AP3-prioritized tumors, including heavily pretreated lung cancers.Disclaimer: This news brief was created by Public Technologies  using generative artificial intelligence","market":"nz","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20260513:nNDL4NNShv:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["BK4139","ACRV"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2635858753","title":"Acrivon Reports First Quarter 2026 Financial Results and Highlights Progress Towards Key 2026 Clinical Catalysts","url":"https://stock-news.laohu8.com/highlight/detail?id=2635858753","media":"THOMSON REUTERS","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2635858753?lang=en_us&edition=fundamental","pubTime":"2026-05-14 04:10","pubTimestamp":1778703002,"startTime":"0","endTime":"0","summary":null,"market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20260513:nTUA17ZQ5Y:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"reuters_en_live","symbols":["BK4139","ACRV"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2635753830","title":"Acrivon Therapeutics, Inc Q1 Income From Operations USD -19.902 Million","url":"https://stock-news.laohu8.com/highlight/detail?id=2635753830","media":"THOMSON REUTERS","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2635753830?lang=en_us&edition=fundamental","pubTime":"2026-05-14 04:10","pubTimestamp":1778703000,"startTime":"0","endTime":"0","summary":null,"market":"nz","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20260513:nPLXC2FE50:3","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"reuters_en_live","symbols":["ACRV","BK4139"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2631632042","title":"Acrivon Therapeutics announces annual shareholder meeting","url":"https://stock-news.laohu8.com/highlight/detail?id=2631632042","media":"Reuters","labels":["conferences","event"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2631632042?lang=en_us&edition=fundamental","pubTime":"2026-04-30 20:34","pubTimestamp":1777552496,"startTime":"0","endTime":"0","summary":"Acrivon Therapeutics will hold its 2026 annual stockholders meeting virtually on June 17, 2026.Shareholders will vote on election of two Class I directors for three-year terms ending in 2029.Disclaimer: This news brief was created by Public Technologies  using generative artificial intelligence. While PUBT strives to provide accurate and timely information, this AI-generated content is for informational purposes only and should not be interpreted as financial, investment, or legal advice. Acrivon Therapeutics Inc. published the original content used to generate this news brief via EDGAR, the Electronic Data Gathering, Analysis, and Retrieval system operated by the U.S. Securities and Exchange Commission , on April 30, 2026, and is solely responsible for the information contained therein.","market":"nz","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20260430:nNDL554K9P:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"conferences,event","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["BK4139","ACRV"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2628781943","title":"Acrivon flags preclinical synergy data for ACR-368, ACR-2316 with PD-L1 blockade","url":"https://stock-news.laohu8.com/highlight/detail?id=2628781943","media":"Reuters","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2628781943?lang=en_us&edition=fundamental","pubTime":"2026-04-18 04:00","pubTimestamp":1776456017,"startTime":"0","endTime":"0","summary":"Acrivon flagged new preclinical combination data for lead cancer drugs ACR-368 and ACR-2316, positioning the results as support for future frontline development strategies.Findings will be presented at AACR 2026 in San Diego across April 19-20.ACR-368 showed synergistic anti-tumor activity in studies pairing it with PD-L1 blockade, supporting a potential immunotherapy combination path.Separate data indicated ACR-2316 combined with anti-PD-L1 drove complete tumor regression in models, with durable immune memory that could strengthen its clinical rationale.Additional results pointed to synergy between ACR-368 and Topo 1 inhibition, a common ADC payload, expanding potential partnering and combination options in ADC regimens.","market":"nz","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20260417:nNDL2RvHvm:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["LU2210149790.SGD","LU2210150020.SGD","IE00B3QW5Z07.USD","IE00BKPKM429.USD","IE00BGHQF748.EUR","LU2095319765.USD","BK4112","IE00BN0W2V16.EUR","BK4139","IE00B64PRP62.GBP","SG9999014021.USD","BK4585","IE00BN0W2T93.GBP","LU0314104364.USD","SG9999014005.SGD","SG9999014039.USD","SG9999014013.SGD","BK4588","IE00BN0W2W23.USD","ACRV","NDAQ"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2627825389","title":"BRIEF-Acrivon Therapeutics Announces Inducement Grant Under Nasdaq Listing Rule 5635(C)(4)","url":"https://stock-news.laohu8.com/highlight/detail?id=2627825389","media":"Reuters","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2627825389?lang=en_us&edition=fundamental","pubTime":"2026-04-16 05:27","pubTimestamp":1776288471,"startTime":"0","endTime":"0","summary":"BRIEF-Acrivon Therapeutics Announces Inducement Grant Under Nasdaq Listing Rule 5635(C)(4)April 15 (Reuters) - Acrivon Therapeutics Inc ACRV.O:ACRIVON THERAPEUTICS ANNOUNCES INDUCEMENT GRANT UNDER NAS","market":"nz","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20260415:nTUA59SM8H:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["BK4139","ACRV"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2627237466","title":"Acrivon Therapeutics grants new hire options to buy 111,150 shares under inducement plan","url":"https://stock-news.laohu8.com/highlight/detail?id=2627237466","media":"Reuters","labels":["shareholding"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2627237466?lang=en_us&edition=fundamental","pubTime":"2026-04-16 04:06","pubTimestamp":1776283598,"startTime":"0","endTime":"0","summary":"Acrivon Therapeutics granted stock options covering 111,150 shares to one new employee under its 2023 Inducement Plan.Grant date was April 15, 2026; exercise price was set at Nasdaq closing price on grant date.Vesting schedule starts with 25% at first anniversary of first day of month following employment effective date.Remaining options vest in 2.083% monthly installments, subject to continued employment.","market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20260415:nNDL11hhWT:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"shareholding","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["IE00BN0W2T93.GBP","ACRV","LU2210150020.SGD","BK4588","BK4585","LU2210149790.SGD","LU0314104364.USD","IE00B64PRP62.GBP","IE00BN0W2V16.EUR","SG9999014005.SGD","IE00B3QW5Z07.USD","NDAQ","IE00BN0W2W23.USD","IE00BKPKM429.USD","SG9999014013.SGD","SG9999014039.USD","BK4139","LU2095319765.USD","BK4112","IE00BGHQF748.EUR","SG9999014021.USD"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2622232548","title":"We're Keeping An Eye On Acrivon Therapeutics' (NASDAQ:ACRV) Cash Burn Rate","url":"https://stock-news.laohu8.com/highlight/detail?id=2622232548","media":"Simply Wall St.","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2622232548?lang=en_us&edition=fundamental","pubTime":"2026-03-27 18:38","pubTimestamp":1774607927,"startTime":"0","endTime":"0","summary":"Even when a business is losing money, it's possible for shareholders to make money if they buy a good business at the...","market":"sg","thumbnail":"https://images.simplywall.st/asset/industry/6111000-choice1-main-header/1585186710114","type":0,"news_type":0,"thumbnails":["https://images.simplywall.st/asset/industry/6111000-choice1-main-header/1585186710114"],"rights":{"source":"simplywall_highlight","url":"https://simplywall.st/stocks/us/pharmaceuticals-biotech/nasdaq-acrv/acrivon-therapeutics/news/were-keeping-an-eye-on-acrivon-therapeutics-nasdaqacrv-cash","rn_cache_url":null,"directOrigin":true},"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://simplywall.st/stocks/us/pharmaceuticals-biotech/nasdaq-acrv/acrivon-therapeutics/news/were-keeping-an-eye-on-acrivon-therapeutics-nasdaqacrv-cash","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"simplywall_highlight","symbols":["ACRV","QYLG","TQQQ","NQmain","PSQ","GPIQ","NVIW.SI","SQQQ","QLD","IYW","JEPQ","FTEC","QDTE","QQQE",".IXIC","QQQY","BK4139","MNQmain","QID","QQQJ"],"isVideo":false,"video":null,"gpt_icon":1},{"id":"2621775060","title":"Jefferies Keeps Their Buy Rating on Acrivon Therapeutics, Inc. (ACRV)","url":"https://stock-news.laohu8.com/highlight/detail?id=2621775060","media":"TIPRANKS","labels":["express"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2621775060?lang=en_us&edition=fundamental","pubTime":"2026-03-23 16:25","pubTimestamp":1774254327,"startTime":"0","endTime":"0","summary":"Jefferies analyst maintained a Buy rating on Acrivon Therapeutics, Inc. on March 20 and set a price target of $14.00. The company’s shares closed l...","market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tipranks_highlight","url":"https://www.tipranks.com/news/blurbs/jefferies-keeps-their-buy-rating-on-acrivon-therapeutics-inc-acrv-blurbs-news?utm_source=itigerup.com&utm_medium=referral","rn_cache_url":null,"directOrigin":true},"property":["rate","earning"],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.tipranks.com/news/blurbs/jefferies-keeps-their-buy-rating-on-acrivon-therapeutics-inc-acrv-blurbs-news?utm_source=itigerup.com&utm_medium=referral","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"express","news_rank":0,"length":0,"strategy_id":0,"source":"tipranks_highlight","symbols":["ACRV"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2620242352","title":"Acrivon Therapeutics Q4 net loss narrows as expenses fall","url":"https://stock-news.laohu8.com/highlight/detail?id=2620242352","media":"Reuters","labels":["dataReport"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2620242352?lang=en_us&edition=fundamental","pubTime":"2026-03-19 19:28","pubTimestamp":1773919721,"startTime":"0","endTime":"0","summary":"Acrivon Therapeutics Q4 net loss narrows as expenses fallOverviewUS biopharma firm's Q4 net loss narrowed from prior year as expenses declinedResearch and development and administrative costs fell, dr","market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20260319:nL1N4070JU:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"dataReport","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["BK4139","ACRV"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2620244005","title":"BRIEF-Acrivon Therapeutics, Inc Q4 Income From Operations USD -20.116 Million","url":"https://stock-news.laohu8.com/highlight/detail?id=2620244005","media":"Reuters","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2620244005?lang=en_us&edition=fundamental","pubTime":"2026-03-19 19:22","pubTimestamp":1773919323,"startTime":"0","endTime":"0","summary":"BRIEF-Acrivon Therapeutics, Inc Q4 Income From Operations USD -20.116 Million\n\n\nMar 19 (Reuters) - Acrivon Therapeutics, Inc Q4 operating expenses USD 20.116 million.\n\nQ4 basic EPS USD -0.49\nQ4 net income USD -18.985 million","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20260319:nPLX4736A5:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["ACRV","BK4139"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2620924404","title":"Acrivon Therapeutics, Inc Q4 Net Income USD -18.985 Million","url":"https://stock-news.laohu8.com/highlight/detail?id=2620924404","media":"THOMSON REUTERS","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2620924404?lang=en_us&edition=fundamental","pubTime":"2026-03-19 19:21","pubTimestamp":1773919278,"startTime":"0","endTime":"0","summary":null,"market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20260319:nPLX4736A5:4","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"reuters_en_live","symbols":["ACRV","BK4139"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2620224400","title":"Press Release: Acrivon Therapeutics Reports Fourth Quarter and Full Year 2025 Financial Results and Recent Business Highlights","url":"https://stock-news.laohu8.com/highlight/detail?id=2620224400","media":"Dow Jones","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2620224400?lang=en_us&edition=fundamental","pubTime":"2026-03-19 19:21","pubTimestamp":1773919260,"startTime":"0","endTime":"0","summary":"Maturing data from the ongoing registrational intent Phase 2b ACR-368 study showed a confirmed overall response rate  of 52% in serous endometrial cancer . Late-breaking oral presentation and corporate KOL panel at ESGO 2026 highlighted strong ACR-368 data in serous EC, a high unmet need subtype responsible for 50% of EC mortality. Initiated Arm 3  and adding Arm 4  Phase 2b cohorts in all-comer  serous EC subjects. Initial Phase 1 ACR-2316 data in AP3-prioritized solid tumor types showed favorable tolerability and promising clinical activity, notably in heavily pre-treated lung cancer subjects. Cash, cash equivalents and marketable securities of $118.6 million as of December 31, 2025, expected to fund operations into the second quarter of 2027. WATERTOWN, Mass., March 19, 2026  -- Acrivon Therapeutics, Inc.  , a clinical stage biotechnology company discovering and developing precision medicines utilizing its proprietary Generative Phosphoproteomics AP3  platform deployed for rational ","market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://dowjonesnews.com/newdjn/logon.aspx?AL=N","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["BK4539","BK4007","EC","BK4201","LENZ","BK4139","ACRV","CLIA"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2620441072","title":"Acrivon FY 2025 net loss narrows 5.4% to USD 77.9 million as interest income falls 29.6% to USD 6.48 million","url":"https://stock-news.laohu8.com/highlight/detail?id=2620441072","media":"Reuters","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2620441072?lang=en_us&edition=fundamental","pubTime":"2026-03-19 19:12","pubTimestamp":1773918723,"startTime":"0","endTime":"0","summary":"Acrivon published an annual report on Form 10-K for the year ended Dec. 31, 2025.Net loss was USD 77.91 million, while net loss per share was USD 2.02.Research and development expense was USD 59.99 million, down 6.25%, mainly due to fewer scheduled and incurred milestones and prioritization of endometrial cancer over other tumor types in the ACR-368 trial.Cash, cash equivalents and investments were USD 118.58 million as of Dec. 31, 2025, and management said this is expected to fund operating expenses and capital expenditure requirements into the second quarter of 2027.Disclaimer: This news brief was created by Public Technologies  using generative artificial intelligence. While PUBT strives to provide accurate and timely information, this AI-generated content is for informational purposes only and should not be interpreted as financial, investment, or legal advice. Acrivon Therapeutics Inc. published the original content used to generate this news brief via EDGAR, the Electronic Data G","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20260319:nNDL3qNmsc:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["ACRV","BK4139"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2620406551","title":"Acrivon Therapeutics to present three posters at the AACR Annual Meeting","url":"https://stock-news.laohu8.com/highlight/detail?id=2620406551","media":"Reuters","labels":["conferences"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2620406551?lang=en_us&edition=fundamental","pubTime":"2026-03-18 05:54","pubTimestamp":1773784463,"startTime":"0","endTime":"0","summary":"Acrivon will present three poster sessions at the AACR Annual Meeting in San Diego, California, held April 17-22, 2026. One poster, “Potent synergy between CHK1/2 inhibitor ACR-368 and the ADC payload topoisomerase 1 inhibitor,” is scheduled for April 19, 2026 from 2:00 p.m. to 5:00 p.m. PT. Two posters are scheduled for April 20, 2026: “ACR-368 synergizes with PD-L1 blockade” from 9:00 a.m. to 12:00 p.m. PT and “Treatment with ACR-2316…combined with anti-PD-L1” from 2:00 p.m. to 5:00 p.m. PT.","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20260317:nNDL6q0clF:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"conferences","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["SG9999014039.USD","IE00B3QW5Z07.USD","BK4139","BK4585","LU2095319765.USD","IE00B64PRP62.GBP","IE00BN0W2T93.GBP","LU0314104364.USD","LU2210149790.SGD","LU2210150020.SGD","SG9999014021.USD","IE00BKPKM429.USD","IE00BN0W2V16.EUR","NDAQ","BK4588","SG9999014013.SGD","IE00BN0W2W23.USD","ACRV","IE00BGHQF748.EUR","SG9999014005.SGD","BK4112"],"isVideo":false,"video":null,"gpt_icon":0}],"pageSize":20,"totalPage":2,"pageCount":2,"totalSize":35,"code":"91000000","status":"200"}]}}